Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2017 Filed Jun 23, 2017 16:00 UTC |
Feldman MariaVP, Clinical Research
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-17-041626 · doc4.xml · derivative · entry 1 Feldman Maria · CIK 0001674083 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2027-06-22 F1 · derivative.exercise_date: Option shares vest and become exercisable in twenty-four (24) successive equal monthly installments measured from June 22, 2017. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:05 UTC |
Knudson Susan A.Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001209191-17-041633 · doc4.xml · derivative · entry 1 Knudson Susan A. · CIK 0001624925 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2027-06-22 F1 · derivative.exercise_date: Option shares vest and become exercisable in twenty-four (24) successive equal monthly installments measured from June 22, 2017. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 21:35 UTC |
Nugent Jeffrey MDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,450 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041269 · doc4.xml · derivative · entry 1 Nugent Jeffrey M · CIK 0001455940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 Underlying: Common Stock · 12,450 shares Expires 2027-06-20 F1 · derivative.exercise_date: Option shares fully vest on the earlier of (i) June 20, 2018, (ii) the day preceding the Issuer's annual meeting of stockholders held in 2018, or (iii) immediately prior to a change of control as contemplated by the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 01:40 UTC |
DEMSKI MARTHA JDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,450 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041270 · doc4.xml · derivative · entry 1 DEMSKI MARTHA J · CIK 0001198230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 Underlying: Common Stock · 12,450 shares Expires 2027-06-20 F1 · derivative.exercise_date: Option shares fully vest on the earlier of (i) June 20, 2018, (ii) the day preceding the Issuer's annual meeting of stockholders held in 2018, or (iii) immediately prior to a change of control as contemplated by the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 01:30 UTC |
Gorbachev MaximDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,450 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-17-041268 · doc4.xml · derivative · entry 1 Gorbachev Maxim · CIK 0001625238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 Underlying: Common Stock · 12,450 shares Expires 2027-06-20 F1 · derivative.exercise_date: Option shares fully vest on the earlier of (i) June 20, 2018, (ii) the day preceding the Issuer's annual meeting of stockholders held in 2018, or (iii) immediately prior to a change of control as contemplated by the Issuer's 2014 Equity Incentive Plan. Read SEC document |
| June 20, 2017 Filed Jun 22, 2017 20:14 UTC |
Kamdar Kim P.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 12,450 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0000904454-17-000452 · edgar.xml · derivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 Underlying: Common Stock · 12,450 shares Expires 2027-06-20 F1 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Issuer, the option vests on the earlier of (i) June 20, 2018, (ii) the day preceding the Issuer's 2018 annual meeting of stockholders, or (iii) immediately prior to a change of control of the Issuer. Read SEC document |
| May 11, 2017 Filed May 11, 2017 20:34 UTC |
Nugent Jeffrey MDirector
|
GrantStock Option (Right to Buy) · Derivative | 63,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001209191-17-031679 · doc4.xml · derivative · entry 1 Nugent Jeffrey M · CIK 0001455940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,500 Underlying: Common Stock · 63,500 shares Expires 2027-05-11 F1 · derivative.exercise_date: Option shares vest and become exercisable in twelve (12) equal monthly installments measured from the vesting commencement date, February 15, 2017, with full acceleration of the option shares upon the event of a change in control. Read SEC document |
| May 11, 2017 Filed May 12, 2017 00:42 UTC |
DEMSKI MARTHA JDirector
|
GrantStock Option (Right to Buy) · Derivative | 63,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001209191-17-031690 · doc4.xml · derivative · entry 1 DEMSKI MARTHA J · CIK 0001198230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,500 Underlying: Common Stock · 63,500 shares Expires 2027-05-11 F1 · derivative.exercise_date: Option shares vest and become exercisable in twelve (12) equal monthly installments measured from the vesting commencement date, February 15, 2017, with full acceleration of the option shares upon the event of a change in control. Read SEC document |
| May 11, 2017 Filed May 15, 2017 21:08 UTC |
Kamdar Kim P.Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 63,500 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000904454-17-000345 · edgar.xml · derivative · entry 1 Kamdar Kim P. · CIK 0001535065 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,500 Underlying: Common Stock · 63,500 shares Expires 2027-05-11 F1 · derivative.exercise_date: The option vests monthly over a one-year period beginning on 2/15/2017, and will fully accelerate upon a change of control of the Issuer. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 15:55 UTC |
Feldman MariaVP Clinical Research & Operati
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001618835-17-000002 · primary_doc.xml · derivative · entry 1 Feldman Maria · CIK 0001674083 · VP Clinical Research & Operati 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2027-03-02 F1 · derivative.exercise_date: (i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 20:47 UTC |
Knudson Susan A.Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001618835-17-000001 · primary_doc.xml · derivative · entry 1 Knudson Susan A. · CIK 0001624925 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-02 F1 · derivative.exercise_date: (i) One half of the option shares vest upon receipt and completed analysis of LIPO-202 CL-31 trial data and (ii) the remaining one half of the option shares vest at the earlier of (a) 12/31/2017 or (b) upon the event of a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.